EarlySense

company

About

EarlySense develops signal-processing technology, offers EverOn, a contact-free and early detection patient supervision system.

  • 101 - 250

Details

Last Funding Type
Series G
Last Funding Money Raised
$25M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2004
Number Of Employee
101 - 250
Operating Status
Active

EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in 2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$92M
EarlySense has raised a total of $92M in funding over 2 rounds. Their latest funding was raised on Jan 7, 2019 from a Series H round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 7, 2019 Series H $39M 1 Detail
Jun 1, 2016 Series G $25M 1 Bank Hapoalim Detail
Nov 12, 2012 Series E $15M 1 Detail
Jul 23, 2010 Series C $13M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
3
EarlySense is funded by 3 investors. Bank Hapoalim and Argo Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Bank Hapoalim Yes Series G
Argo Capital Partners Series H
Bridge Investment Fund Series E